Merger Announced
DT Cloud Star Acquisition and PrimeGen US merger
US$1.5bn equity value
Announced 2 Feb 2026
Advisers
PrimeGen US
Target
- Financial adviser
- Legal adviser
- Schinko Law
- Target
- PrimeGen US
- Acquirer
- DT Cloud Star Acquisition
- Target based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Cell Therapy
In the league tables
Similar deals
- AstraZeneca acquisition of AbelZeta's 50% share of China development and commercialisation rights to C-CAR031 Jan 2026 · US$630m · Biotech
- UCB acquisition of Neurona Therapeutics Apr 2026 · US$650m · Biotech
- Galera Therapeutics and Obsidian Therapeutics merger Apr 2026 · US$414m · Biotech
- Eli Lilly and Company acquisition of Kelonia Therapeutics Apr 2026 · US$7bn · Biotech
- Gilead Sciences acquisition of Arcellx Feb 2026 · US$7.8bn · Biotech